Skip to main
GL

GL Stock Forecast & Price Target

GL Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 56%
Hold 22%
Sell 0%
Strong Sell 0%

Bulls say

Globe Life Inc. is projected to achieve life premium growth of 4.0%-4.5% and a significant 14%-16% rise in health premiums in the coming year, driven by an anticipated 10% increase in leads for its exclusive agencies. Management has reported favorable mortality experience, contributing to a 3Q remeasurement gain of $150 million, with Life gains reaching $18 million, which reflects the strong performance trajectory of the company's insurance products. Furthermore, the company has increased its 2025 earnings per share (EPS) estimate to $14.50 and maintained a forecast of $15.05 for 2026, reinforcing investor confidence in its long-term growth expectations.

Bears say

Globe Life Inc is facing a negative outlook primarily due to projected operating earnings per share growth of only 3% at the midpoint for 2026, which is significantly lower than its historical average, partly because of anticipated reduced life remeasurement gains. Additionally, the company encounters multiple risks including potential fines or reputational damage from an ongoing EEOC review, heightened margin pressure from increased health utilization, and challenges in recruiting an effective salesforce that could hinder revenue prospects. Furthermore, while the company's underwriting margins are expected to decrease, the shift toward Medicare Supplement products—despite low capital requirements—indicates potential profitability concerns given their lower profit margins.

GL has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 56% recommend Buy, 22% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Globe Life Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Globe Life Inc (GL) Forecast

Analysts have given GL a Buy based on their latest research and market trends.

According to 9 analysts, GL has a Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $169.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $169.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Globe Life Inc (GL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.